Fiona M. Cunningham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fiona M. Cunningham has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Simon Bailey
Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, Australia
4 shared publications - P. Lees
Royal Veterinary College University of London London UK
3 shared publications - Jonathan Elliott
Department of Comparative Biomedical Sciences Royal Veterinary College Hertfordshire UK
2 shared publications A. P. Foster
Department of Veterinary Basic Sciences, The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire, UK
1 shared publicationAnne S. Hamblin
1 shared publicationBettina Dunkel
1 shared publication
Latest Publications
- 1 September 2008
- Published by Elsevier in The Veterinary Journal
- Vol. 177 (3) , 334-344
Equine recurrent airway obstruction and insect bite hypersensitivity: Understanding the diseases and uncovering possible new therapeutic approaches
- 1 September 2008
- Published by Elsevier in The Veterinary Journal
- Vol. 177 (3) , 334-344
Equine recurrent airway obstruction and insect bite hypersensitivity: Understanding the diseases and uncovering possible new therapeutic approaches
- 1 September 2003
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 95 (1-2) , 63-72
Cloning, expression and biological activity of equine interleukin (IL)-5
- 1 September 2003
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 95 (1-2) , 63-72
Cloning, expression and biological activity of equine interleukin (IL)-5
- 23 July 2003
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 26 (4) , 277-282
Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation
Compounds that activate adenylate cyclase, increasing intracellular cyclic adenosine monophosphate (cAMP), inhibit equine platelet aggregation. Cyclic AMP is broken down by phosphodiesterase (PDE) and, in the present study, the effects of theophylline, a nonselective PDE inhibitor, and selective inhibitors of PDE isoenzymes PDE3, PDE4 and PDE5, on equine platelet aggregation in response to platelet activating factor (PAF) and adenosine diphosphate (ADP) have been examined. Theophylline and the PDE3 inhibitors, trequinsin and quazinone, inhibited both PAF and ADP‐induced aggregation in a concentration dependent manner. The inhibition of PAF‐induced aggregation was, however, significantly greater than that of the response to ADP. The inhibitory effects of theophylline and the PDE3 inhibitors on ADP‐ but not PAF‐, induced aggregation were reversed by addition of the calcium ionophore, A23187. Rolipram and zaprinast, inhibitors of PDE4 and PDE5, respectively, had no effect on either PAF‐ or ADP‐induced aggregation. These results demonstrate that inhibition of aggregation caused by PAF or ADP can be achieved by selective inhibition of PDE3 but suggest that there may be agonist‐specific differences in the intracellular signalling pathways that regulate equine platelet aggregation.
- 23 July 2003
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 26 (4) , 277-282
Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation
Compounds that activate adenylate cyclase, increasing intracellular cyclic adenosine monophosphate (cAMP), inhibit equine platelet aggregation. Cyclic AMP is broken down by phosphodiesterase (PDE) and, in the present study, the effects of theophylline, a nonselective PDE inhibitor, and selective inhibitors of PDE isoenzymes PDE3, PDE4 and PDE5, on equine platelet aggregation in response to platelet activating factor (PAF) and adenosine diphosphate (ADP) have been examined. Theophylline and the PDE3 inhibitors, trequinsin and quazinone, inhibited both PAF and ADP‐induced aggregation in a concentration dependent manner. The inhibition of PAF‐induced aggregation was, however, significantly greater than that of the response to ADP. The inhibitory effects of theophylline and the PDE3 inhibitors on ADP‐ but not PAF‐, induced aggregation were reversed by addition of the calcium ionophore, A23187. Rolipram and zaprinast, inhibitors of PDE4 and PDE5, respectively, had no effect on either PAF‐ or ADP‐induced aggregation. These results demonstrate that inhibition of aggregation caused by PAF or ADP can be achieved by selective inhibition of PDE3 but suggest that there may be agonist‐specific differences in the intracellular signalling pathways that regulate equine platelet aggregation.
- 28 March 2003
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 26 (2) , 131-138
Substance P induces activation, adherence and migration of equine eosinophils
The tachykinin, substance P (SP), affects eosinophil function by direct and indirect mechanisms and has been shown to cause equine eosinophils to adhere to vascular endothelium and to release cytokines that increase cell adherence. The aim of this study was to determine whether SP could act directly on equine eosinophilsin vitro. Eosinophil activation was also compared in cells from normal ponies and those with insect hypersensitivity as SP may be released in the skin of hypersensitive animals. SP caused equine eosinophils to adhere, migrate and produce superoxide, although high concentrations were required to produce these effects [10 ± 2% adherence, 45 ± 20 cells/0.3 mm2and 48 ± 7 nmol (of reduced cytochrome C)/106cells, respectively, at 3 × 10−4 m]. That the 7–11, but not the 1–7, amino acid fragment of SP caused superoxide production, suggested the effects of SP were receptor mediated. Eosinophils from hypersensitive ponies produced more superoxide in response to SP, but not phorbol myristate acetate or histamine, over the concentration range tested when compared with cells from normal ponies. The data obtained in this study suggest that although SP can directly activate equine eosinophils, in view of the high concentrations required, such actions may be of less relevance physiologically than other SP‐mediated effects.
- 28 March 2003
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 26 (2) , 131-138
Substance P induces activation, adherence and migration of equine eosinophils
The tachykinin, substance P (SP), affects eosinophil function by direct and indirect mechanisms and has been shown to cause equine eosinophils to adhere to vascular endothelium and to release cytokines that increase cell adherence. The aim of this study was to determine whether SP could act directly on equine eosinophilsin vitro. Eosinophil activation was also compared in cells from normal ponies and those with insect hypersensitivity as SP may be released in the skin of hypersensitive animals. SP caused equine eosinophils to adhere, migrate and produce superoxide, although high concentrations were required to produce these effects [10 ± 2% adherence, 45 ± 20 cells/0.3 mm2and 48 ± 7 nmol (of reduced cytochrome C)/106cells, respectively, at 3 × 10−4 m]. That the 7–11, but not the 1–7, amino acid fragment of SP caused superoxide production, suggested the effects of SP were receptor mediated. Eosinophils from hypersensitive ponies produced more superoxide in response to SP, but not phorbol myristate acetate or histamine, over the concentration range tested when compared with cells from normal ponies. The data obtained in this study suggest that although SP can directly activate equine eosinophils, in view of the high concentrations required, such actions may be of less relevance physiologically than other SP‐mediated effects.
- 7 June 2001
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 24 (3) , 209-214
Inflammatory mediators induce endothelium‐dependent adherence of equine eosinophils to cultured endothelial cells
Accumulation of equine eosinophils at sites of parasite infestation or allergic inflammation depends upon their adherence to vascular endothelial cells and subsequent migration through the endothelium and extracellular matrix. This study has examined whether cytokines, which cause endothelial cell‐dependent eosinophil adherence in other species, and histamine and substance P, which increase adherence of equine eosinophils to protein coated plastic, induce equine eosinophil adherence to cultured equine digital vein endothelial cell (EDVEC) monolayers. The EDVEC monolayers were stimulated with recombinant human (rh) interleukin (IL)‐1β, rhTNFα, substance P or histamine for different times and with a range of concentrations of mediators and the adherence of blood eosinophils from normal horses examined. All four mediators caused time‐ and concentration‐dependent increases in adherence. However, neither the response to substance P, nor that to histamine, reached a maximum at the highest concentration tested (10–3 M: 10.6 ± 2.6% and 4.5 ± 0.6% adherent cells vs. background adherence of 1.9 ± 0.4% and 1.1 ± 0.2%; values for substance P and histamine, respectively, expressed as a percentage of total cells added initially;n=4). These data suggest that, as in other species, cytokines induce endothelial cell‐dependent eosinophil adherence and mediators released during allergic inflammation may play a role in eosinophil recruitment by this mechanism.
- 7 June 2001
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 24 (3) , 209-214
Inflammatory mediators induce endothelium‐dependent adherence of equine eosinophils to cultured endothelial cells
Accumulation of equine eosinophils at sites of parasite infestation or allergic inflammation depends upon their adherence to vascular endothelial cells and subsequent migration through the endothelium and extracellular matrix. This study has examined whether cytokines, which cause endothelial cell‐dependent eosinophil adherence in other species, and histamine and substance P, which increase adherence of equine eosinophils to protein coated plastic, induce equine eosinophil adherence to cultured equine digital vein endothelial cell (EDVEC) monolayers. The EDVEC monolayers were stimulated with recombinant human (rh) interleukin (IL)‐1β, rhTNFα, substance P or histamine for different times and with a range of concentrations of mediators and the adherence of blood eosinophils from normal horses examined. All four mediators caused time‐ and concentration‐dependent increases in adherence. However, neither the response to substance P, nor that to histamine, reached a maximum at the highest concentration tested (10–3 M: 10.6 ± 2.6% and 4.5 ± 0.6% adherent cells vs. background adherence of 1.9 ± 0.4% and 1.1 ± 0.2%; values for substance P and histamine, respectively, expressed as a percentage of total cells added initially;n=4). These data suggest that, as in other species, cytokines induce endothelial cell‐dependent eosinophil adherence and mediators released during allergic inflammation may play a role in eosinophil recruitment by this mechanism.
- 1 February 2001
- Published by Springer Nature in Inflammation Research
- Vol. 50 (1) , 32-38
Adherence of eosinophils from allergic and normal ponies to cultured equine endothelial cells
Objectives: To compare adherence of stimulated and unstimulated eosinophils from allergic and normal ponies to cultured equine vascular endothelial cells (equine digital vein endothelial cells; EDVEC) and examine the effect of eosinophil-derived factor(s) on cell adherence.¶Methods: Eosinophil adherence to unstimulated EDVEC or EDVEC pretreated with IL-1β or supernatants from stimulated eosinophils was measured. Supernatants were also assayed for TNFα and IL-1β-like bioactivity.¶Results: Adherence of unstimulated and rhIL-5 (10 ng/ml)-stimulated eosinophils from allergic ponies to rhIL-1β-treated EDVEC was significantly greater than that of cells from normal ponies. Pretreatment of EDVEC with supernatants from stimulated eosinophils from both groups of ponies significantly increased adherence of autologous cells and IL-1β- and TNFα-like bioactivities were detected in the supernatants.¶Conclusions: Mediator-induced activation of equine eosinophils may lead to further eosinophil recruitment by releasing cytokines that up-regulate endothelial cell adhesion molecule expression. Increased adherence of blood eosinophils from allergic ponies to stimulated endothelium could be explained by in vivo priming.¶
- 1 February 2001
- Published by Springer Nature in Inflammation Research
- Vol. 50 (1) , 32-38
Adherence of eosinophils from allergic and normal ponies to cultured equine endothelial cells
Objectives: To compare adherence of stimulated and unstimulated eosinophils from allergic and normal ponies to cultured equine vascular endothelial cells (equine digital vein endothelial cells; EDVEC) and examine the effect of eosinophil-derived factor(s) on cell adherence.¶Methods: Eosinophil adherence to unstimulated EDVEC or EDVEC pretreated with IL-1β or supernatants from stimulated eosinophils was measured. Supernatants were also assayed for TNFα and IL-1β-like bioactivity.¶Results: Adherence of unstimulated and rhIL-5 (10 ng/ml)-stimulated eosinophils from allergic ponies to rhIL-1β-treated EDVEC was significantly greater than that of cells from normal ponies. Pretreatment of EDVEC with supernatants from stimulated eosinophils from both groups of ponies significantly increased adherence of autologous cells and IL-1β- and TNFα-like bioactivities were detected in the supernatants.¶Conclusions: Mediator-induced activation of equine eosinophils may lead to further eosinophil recruitment by releasing cytokines that up-regulate endothelial cell adhesion molecule expression. Increased adherence of blood eosinophils from allergic ponies to stimulated endothelium could be explained by in vivo priming.¶
- 1 May 2000
- Published by Springer Nature in Inflammation Research
- Vol. 49 (5) , 224-230
Differential activation of platelets from normal and allergic ponies by PAF and ADP
Objective and Design: Altered platelet responsiveness has been demonstrated in human atopic dermatitis. This study has compared the in vitro function of platelets from normal ponies and those with the allergic skin disease, sweet itch.¶Subjects: Ponies with a clinical history of sweet itch and normal ponies were used as blood donors.¶Methods: PAF and ADP-induced platelet aggregation was measured and TxB2 production quantitated at the time of maximal aggregation; 12-HETE was additionally measured in some samples. Agonist-induced release of 3[H]5-HT was also studied.¶Results: Although both PAF and ADP caused equine platelet aggregation, only PAF stimulated eicosanoid and 5-HT release. There were no differences between the responses of platelets from allergic and normal ponies to PAF or ADP (analysis of variance).¶Conclusions: There is no evidence of altered platelet responsiveness in ponies with sweet itch. The profile of responses to PAF and ADP suggest differential activation of intracellular signalling pathways in equine platelets.
- 1 May 2000
- Published by Springer Nature in Inflammation Research
- Vol. 49 (5) , 224-230
Differential activation of platelets from normal and allergic ponies by PAF and ADP
Objective and Design: Altered platelet responsiveness has been demonstrated in human atopic dermatitis. This study has compared the in vitro function of platelets from normal ponies and those with the allergic skin disease, sweet itch.¶Subjects: Ponies with a clinical history of sweet itch and normal ponies were used as blood donors.¶Methods: PAF and ADP-induced platelet aggregation was measured and TxB2 production quantitated at the time of maximal aggregation; 12-HETE was additionally measured in some samples. Agonist-induced release of 3[H]5-HT was also studied.¶Results: Although both PAF and ADP caused equine platelet aggregation, only PAF stimulated eicosanoid and 5-HT release. There were no differences between the responses of platelets from allergic and normal ponies to PAF or ADP (analysis of variance).¶Conclusions: There is no evidence of altered platelet responsiveness in ponies with sweet itch. The profile of responses to PAF and ADP suggest differential activation of intracellular signalling pathways in equine platelets.
- 20 September 1999
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 71 (2) , 77-88
Agonist-induced adherence of equine neutrophils to fibronectin- and serum-coated plastic is CD18 dependent
- 20 September 1999
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 71 (2) , 77-88
Agonist-induced adherence of equine neutrophils to fibronectin- and serum-coated plastic is CD18 dependent